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Abstract 
Anti-Epileptic Drugs (AEDs) are the main therapy for epilepsy to prevent seizures. Non-adherence situation plays 
an important factor in the failure of seizure control. Such a condition may generate several impacts on clinical, 
social, and economic aspect. Several methods are used to measure adherence in epilepsy patients, including 
direct and indirect measurement. The direct measure involves measurement of drug levels in hair or body fluids 
such as blood and saliva. Whereas, indirect measure involves the non-biological tools, for example, a self-report 
measure, pill counts, appointment attendance, medication refills, and seizure frequency. Numerous factors may 
affect adherence in epilepsy patients, such as age, sex, and seizure aetiology, seizure sites, which are 
categorised as irreversible factors and hardly to be improved. However, there are factors that can be influenced to 
improve adherence such as patient knowledge, medication, cultural, health care professionals, and national 
health policies, which are related to treatment and education factor which is associated with behaviour to be likely 
adherence. 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Epilepsy is an unprovoked seizure condition, 
while epileptic status is a seizure activity that does not 
improve spontaneously or seizures repeatedly without 
any improvement between seizures [1] [2]. Based on 
the duration, seizure, when the duration is less than 5 
minutes, if the duration between 5 to 30 minutes is 
categorised as prolonged seizure, while status 
epilepticus is defined as seizure, occurs with duration 
greater than 30 minutes, or repeated seizure activity 
(2 x or more) with or without any improvement in 
awareness among repeated seizures [3]. Epilepsy is a 
chronic brain disease characterised by recurrent 
seizures (2 or more times), involving partial body, 
involuntary movements, and often accompanied by 
loss of consciousness and control of gastrointestinal 
or urinary tract function. Approximately, 4 to 10 in 
1000 people are predicted suffering from active 
epilepsy and persistent seizures. Additionally, a study 
of epilepsy in developing countries population 
indicated that the prevalence of epilepsy is higher, 
with a ratio of 7 to 14 in 1000 people [4]. 
Anti-epileptic drugs (AEDs) are the main 
therapy for epilepsy to prevent seizures thoroughly 
and an easy to follow a treatment schedule. 
Approximately 67% of patients with epilepsy could 
reduce or even combat their seizure frequency 
effectively using AEDs [5]. As a result, it is indicated 
that the substance could control epilepsy symptom, 
which is shown as seizure free at least for 18 months 
[6]. On the other hand, uncontrolled epilepsy is 
illustrated with considerably uncontrolled seizures with 
a high frequency of its symptoms. A study implied that 
this condition might cause disruption and even 
degradation of the quality of life of the patients [7]. 
Non-adherence is considered as one of the 
most important factors for controlling epileptic 
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seizures. It is acknowledged as a worldwide health 
problem and has impacts on clinical, social, and 
economic outcomes [8]. Non-adherence includes 
prescription or delay inappropriate failure dose, and 
missed dose of treatment [9]. Many retrospective 
studies have demonstrated the most crucial impact of 
non-adherence in AEDs. It was identified that non-
adherence would increase costs due to hospitalisation 
as well as a decrease in productivity [10] [11] [12]. 
Therefore, identifying obstacles to AEDs adherence is 
important to allow practitioners are developing 
appropriate strategies to improve adherence [10]. 
Patients need support and specific information to 
achieve adherence.  
This literature review is developed to address 
the importance of AEDs adherence factors for 
improving clinical outcomes for patients with epilepsy. 
  
 
Discussion 
 
Adherence is the extent to which a person’s 
behaviour-taking medication, following a diet, and/or 
executing lifestyle changes, corresponds with agreed 
recommendations from a healthcare provider [13]. 
Adherence implies that health professionals have a 
responsibility to form a therapeutic relationship with 
patients, to encourage them to agree to a 
recommended treatment regimen. This means that 
patients should be better informed about their 
medicines, and in theory, have greater power to 
decline treatment [14].  
Adherence in AEDs, defined as the extent to 
which patients follow the agreed instructions given by 
the prescribers and persistence in a regimen of 
treatment epilepsy such as the duration of initiation for 
discontinuation of therapy [15]. The World Health 
Organization (WHO) has concluded that increasing 
the effectiveness of adherence may have a greater 
impact on the health of the population than any 
improvement in specific medical treatments [16]. 
Drug adherence can be used to predict the 
remission condition in epilepsy. Non-adherence term 
may cause breakthrough attacks at several months or 
years after the previous episode of seizure [17]. It is 
indicated that patients who adhere a routine use 
AEDs, have 6, 12 and 24 months continuous 
remissions compared to those non-adherence 
patients. An adherence to epilepsy is a milestone of 
the success and the effectiveness of pharmacological 
therapies. It has impacts in helping to prevent seizure 
events and reducing the cumulative negative impact 
of seizures in daily life [18]. 
Non-adherence of AEDs in epilepsy patients 
may cause an increased risk of convulsive status 
epilepticus [19]. And the most serious consequence of 
non-adherence would be the increased risk of sudden 
unexplained death in epilepsy patients. Due to those 
consequences, identifying the barriers to adherence of 
AEDs is observed as imperative to allow practitioners 
are developing some appropriate strategies to 
improve adherence rates [20]. 
Table: 1 Method to Measure Adherence in Epilepsy Patients 
[21] 
Measures 
adherence 
Method Disadvantages Advantages 
Direct Measures    
Plasma or serum 
Antiepileptic drug 
levels 
Plasma or serum levels of 
medication are measured 
Patient factors (albumin, 
hepatic & kidney condition) 
and drug types can 
Cause measurement 
variability 
 
Commonly used, well 
understood by 
Clinicians, effective in 
extreme low adherence 
situations, to determine 
the range of therapy and 
the possibility of 
overdose-related side 
effects 
Detection in human 
hair 
Hair medication levels 
analysed using gas or liquid 
chromatography 
Researchers disagree on 
the effectiveness 
Less invasive than blood 
testing 
Saliva antiepileptic 
drug concentration 
Levels of aeds excreted in 
saliva are measured 
Measurement must be 
calibrated to individual 
saliva production and 
serum/saliva medication 
ratios 
Painless, does not 
require venous access 
(good for pediatric and 
geriatric patients); as 
accurate as blood plasma 
or serum monitoring 
Indirect Measures    
Self-report 
measures 
Patient reports medication 
adherence through methods 
such as survey or interviews 
No standardised and 
validated 
Measures exist for epilepsy 
treatment adherence; can 
be inaccurate due to patient 
misperceptions or tendency 
to give a desirable 
response 
Low cost; not physically 
invasive; adaptable to the 
target population 
Pill counts Doses monitored through 
counts of remaining pills or 
use of an event recorder 
Does not guarantee that 
medication is taken outside 
of a controlled environment 
Not physically invasive; 
event recorders measure 
regularity of dosing 
Appointment 
attendance 
The regularity of attendance 
at appointments is 
documented 
Tends to be the limited 
term, while epilepsy is 
lifelong; not proof of proper 
medication use 
Easy to collect 
information can be 
related to others 
adherence behaviours 
Medication refills Medical/pharmacy records 
reviewed to see if medication 
is refilled at appropriate 
intervals 
Not proof of proper 
medication use 
Can be correlated to 
blood serum levels 
Seizure Frequency The frequency of seizures is 
logged over time 
Non-adherence patients 
may not have frequent 
seizures 
An essential indication of 
the degree to which 
epilepsy is managed 
 
From the literature, there are two types of 
poor adherence, which are primary non-adherence 
and secondary non-adherence. Primary non-
adherence is implied in a condition where the patient 
does not have a prescription for medicine dispensed. 
Meanwhile, the secondary non-adherence is defined 
as the patient has medicine dispensed but does not 
take medicine according to the prescribed regimen 
[14]. Another study implied there are three types of 
non-adherence: (i) in medication; (ii) in 
dietary/exercise; and (iii) in an appointment. First, 
non-adherence in medication defined as a non-
adherence which includes failure to have the 
prescription dispensed or renewed, the omission of 
doses, errors of dosage, incorrect administration, 
errors in the time or frequency of administration, and 
premature discontinuation of the drug regimen. 
Second, a non-adherence in dietary/exercise occurs if 
the patient fails to follow the diet and exercise 
recommendations. Last, a non-adherence in an 
appointment occurs if the patient fails to come at 
clinics for the scheduled check-up [15]. 
Two different methods to measure adherence 
are direct and indirect measurements. Direct 
measurement includes a measurement of drug levels 
in hair or body fluids such as blood or saliva. Indirect 
measurement involves non-biological tools, such as 
self-report measures, pill counts, appointment 
attendance, medication refills, and seizure frequency 
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(Table 1) [21]. 
A study on adherence of epilepsy patients 
with an indirect measure to treatment includes 
adherence to outpatient epilepsy treatment in Saudi 
Arabia. There were 38.3% of patients who did not 
adhere to the prescribed drug based on self-reported 
measurement of Morisky Medication Adherence Scale 
(MMAS) score [9]. Another study on adherence in 
some hospitals in Ethiopia for treating epilepsy 
indicated that prevalence of AEDs non-adherence is 
about 37.8% [22].  
WHO has identified five dimensions of 
influencing factors on patient adherence, which are: (i) 
social/economic factors; (ii) health system/healthcare 
team factors; (iii) condition-related factors; (iv) 
therapy-related factors; and (v) patient-related factors 
[13]. A systematic review regarding adherence in 
epilepsy therapy implied that the factors that influence 
patient adherence are including factors in patients, 
confidence in treatment, depression and anxiety, 
treatment management, disease factors, factors 
related to medication, health care factors, and socio-
economic factors (Table 2) [20].  
Patient age is associated with different levels 
of adherence. For example, adolescents tend to deny 
that a medication regimen can impose on their lives. 
On the other hand, a patient with older ages might be 
not adhered to medication due to the complexity of 
medication regimens and presence of multiple 
comorbidities [14].  
The seizures that characterise primary 
epilepsy have been considered to be signs of demonic 
possession. It also can be affected by depression and 
anxiety patients, thus influencing the adherence. A 
study from Shallcross et al., [23] about non-adherence 
to a regimen with AEDs reported that there is a 
significant correlation between being depressed and 
non-adherence with a score of -0.379 on Pearson 
correlation coefficient and rates of probability values 
being P < 0.05. Another study conducted in Southern 
Ethiopia indicated that the most common of non-
adherence were forgetfulness (75.4%) and ran out of 
pills (10.8%). Furthermore, the study illustrated that 
duration of epilepsy treatment, marriage status, level 
of education, and the absence of comorbidity may 
affect adherence to medication.  
Medication factor is another important factor 
that might affect adherence. For example, complex 
dose regimens are associated with poor adherence 
due to the difficulties of drug administration. 
Medication regimens can be complex because they 
contain multiple different medicines (polypharmacy), 
or because they need to be taken frequent times a 
day. A study indicated that adherence is much lower 
with regimens that require medication to be taken 
three or four times daily, by 65% and 51% 
respectively compared to once daily dose [24]. 
Moreover, two types of research about adherence in 
patients with epilepsy to take AEDs observed that 
forgetting the dose and administration time were given 
contributions for non-adherence [25] [26].  
Another patient’s related factor that influence 
of adherence is patient’s belief in medication and 
health professionals. The types of patient’s beliefs 
about medicines are perceived efficacy of medicine, 
the danger of becoming immune over time, 
unnaturalness of manufactured medicines, the danger 
of addiction and dependence, anti-drug attitude and 
balancing risks and benefits that all types of patient’s 
belief can influence of adherence [14]. To overcome 
the problem, a good relationship and communication 
between patients and health professionals are likely in 
helping patients to adhere to their medication. 
Maintaining contact between patients and health 
professionals is required to achieve patient adherence 
[27]. Conversely, healthcare systems with poorly 
trained or overworked health professionals, short 
consultation times, inadequate patient education and 
follow-up, and lack of help for patients to pay for 
treatment can contribute to poor adherence [14]. 
Hovinga et al., [28] investigated that adherence 
percentage in patients who trust their doctor is higher 
by 34% compared to 17% in patients who have lower 
trust. This indicates that the impact of the patient and 
physician relationship can affect adherence. 
Furthermore, adherence participants reported being 
comfortable discussing missed medications with their 
doctor can be decreased non-adherence medication.  
Other potential factors that may cause non-
adherence in patients with epilepsy from an area with 
the low-quality health care system are level of 
healthcare development, cultural belief, economy, 
distance from health care facilities, supply antiepileptic 
drug, lack priority in national health policies, and belief 
in traditional medicine [29]. In some area, there were 
various misunderstandings and stigma about epilepsy 
that can affect adherence to epilepsy. A study in 
Vientiane, the capital city of Lao Peoples' Democratic 
Republic (Lao PDR), observed that epilepsy was 
acknowledged as a disease caused by supernatural 
powers or ancestral factors [30]. This negative stigma 
may diminish appropriate treatment for patients with 
epilepsy [31]. Moreover, the stigma may affect the 
level of knowledge about the proper treatment of 
patients, their family, and the society. The low level of 
knowledge about the treatment would trigger the trust 
in traditional medicine utilisation [29]. 
Table 2: Factors Affecting Medication Adherence in Epilepsy 
Patients 
Aspect Factors affecting medication adherence in epilepsy patients, 
ethnic origin (the cultural belief that epilepsy is a disease that has 
supernatural manifestations (associated with ancestors or evil 
spirits) 
Patients factors Age, sex, confidence in treatment, depression & anxiety 
Disease factors The onset of epileptic, aetiology of the seizures, the location of the 
epileptogenic zone 
Medication factors Treatment management (monotherapy or polytherapy), adverse 
effect of AED, beliefs in medication 
Health care factors Belief in health care providers (clinician, pharmacist) 
Socioeconomic factors Cost of treatment and income patients 
Distance from 
healthcare facilities 
The measure of distance from the health service can affect the 
level of adherence and the type of treatment the epilepsy patient 
receives 
National health 
policies 
The lack of prioritisation in national health policies can affect the 
treatment of epilepsy 
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Essential strategies to improve medication 
adherence with long-term therapy involve multiple 
interventions are: more convenient care, 
comprehensive information, a reminder to take 
medication, self-monitoring of treatment effectiveness, 
psychological therapy, and telephone follow-up [14]. 
Pharmacological intervention in people with epilepsy 
is only one aspect of their management in medication. 
Patients with epilepsy also require support from the 
society as having epilepsy has a widespread effect 
and impact psychologically on the social life [18].  
Another approach to improve adherence is 
the involvement of other health workers such as 
pharmacist in the provision of education and changes 
in the behaviour patterns of epilepsy patients to 
treatment. A study in China described that providing 
educational interventions through counselling could 
alter the patient behaviour to be more concern about 
the administration schedules. This may provide a 
better effect on the level of medication adherence with 
a reduction in the percentage of the forgetful taking of 
drugs from more than 70% to 45% [32]. 
According to Cochrane database of 
systematic reviews, the strategies for improving 
adherence to AEDs consist of three interventions, 
which are educational, behavioural, and mixed 
interventions [33]. Additionally, several supporting 
approaches, such as reminder systems, cognitive 
educational, behavioural counselling, social support 
(family member support), and multifaceted 
interventions (reminder systems combined with 
cognitive, educational interventions) were observed as 
efficient methods to improve adherence [34] [35] [36].  
Communication and information about 
pharmacological treatment and diseases are 
important. Providing comprehensive information as an 
education intervention must be focused not only on 
patients but also on others like family. To achieve 
better adherence, it is required to provide information 
to the patient about their disease, how to manage 
missing dose, the importance of adherence, in need of 
adopting patient-centered care, and sharing decision. 
Decreasing number of patients who missed the AEDs 
along with an increased percentage of patients taking 
the AEDs were the results of a positive effect of the 
educational intervention. Education has become the 
most common strategy used by many researchers to 
improve adherence [32]. 
Health education is a powerful tool, which can 
give a positive impact on both drug adherence and 
self-management ability in patients with epilepsy. 
From a study from Dash et al. [18], it is observed that 
the epilepsy health education group, can affect 
different MMAS score from 6.58 to 7.53 (P = 0.001), 
and indicated that health education is significant to 
improve adherence. 
Another research about the impact of 
pharmacist educational interview on medication of 
Saudi Arabia showed a significantly different result in 
post-intervention for epilepsy patients with education 
intervention (P = 0.024) [37]. Medication education 
provided by the pharmacist helped to improve 
adherence, seizure control, and the knowledge of 
AEDs.  
Provision of an educational intervention on 
epilepsy treatment, especially in a region that has a 
belief that epilepsy is a disease with ancestral cultural-
influence should be conducted together with cultural 
approaches to the family and carried out continuously 
with long-term education [29]. Family support is a 
major strategy in the treatment of epilepsy, but it is 
challenging when families feel ashamed of having a 
family with epilepsy [38] [39]. Hence, communication 
and information about the disease and therapy for 
patients with epilepsy must be provided as an 
educational intervention to the family as well. In other 
words, an intervention with a single component or 
intervention (information or education) seems to be 
ineffective to improve adherence or other clinical 
outcomes, but there is some evidence that education 
intervention may improve knowledge.  
Behavioural interventions are characterised 
by the cognitive behavioural techniques and therapies 
focused on dysfunctional emotions, behaviours and 
cognitions with the aim to promote healthy lifestyles 
and positive changes toward symptoms or treatment 
[40]. Additionally, behavioural interventions are aimed 
to change individual behaviour in those aspects 
related to their daily life, which can modify patient’s 
behaviour toward treatment. Intensive treatment 
reminders provide favourable effects on adherence 
(moderate-quality evidence) and can be conducted by 
suggesting the patient consume the drug with the 
place and other routine activities, thus minimising the 
forgetting to take the drug. This tool for improving 
adherence in patients who are forgetting to take their 
medications, much less research has shown that 
forgetfulness is found to be the main reason for non-
adherence in patients with epilepsy [41]. 
Mixed intervention is a combination of one or 
more interventions, both educational and behavioural, 
which can be performed by health professionals. The 
mixed intervention was intended to help patients 
incorporate drug administration into their daily lives. 
The European Declaration on Epilepsy recommends 
interdisciplinary action to help people with epilepsy 
understand their condition and do the search for a 
proper treatment possible in order to improve their 
quality of life such as pharmaceutical care and give 
significantly improves quality of life (QOLIE-31 score 
for the intervention group was 12.45 points (P-value < 
0.001) compared to the control group it was 2.61 (P-
value = 0.072) [17]. All interventions to improve the 
quality of treatment of epilepsy patients should be 
based on local perceptions, social conditions and 
cultural backgrounds as well as the spirits possession 
of epilepsy patients [31]. And understanding why 
patients do not take their medicines can help to avoid 
some of this frustration and, in some cases, enable 
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health professionals to improve patient adherence. 
In conclusion, adherence to AEDs for patients 
with epilepsy is an important factor and affects the 
outcome of seizure control. Several irreversible 
factors may affect treatment adherence in epilepsy 
patients, including such as age, sex, seizure 
aetiology, seizure sites. However, there are reversible 
factors that can be altered by conducting the 
approaches to improve patient adherence including 
patient knowledge and treatment regimens, cultural 
factor, health care factors, and national health 
policies. Various interventions to improve clinical 
outcome of epileptic seizure control are behaviour 
interventions, educational or combination of some of 
this intervention. 
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